<!DOCTYPE html SYSTEM "about:legacy-compat">
<html xmlns:ns0="http://www.w3.org/2001/XInclude" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>DC Code - § 48–902.14. Treatment of controlled substance analogues.</title>
    <meta property="st:title" content="&#xA7; 48&#x2013;902.14. Treatment of controlled substance analogues."/>
    <meta name="description" content="A simple, free browser for the Washington, DC Code"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/reset.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/site.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/body.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <link rel="stylesheet" type="text/css" href="/css/icons/style.css" media="screen"/>
    <script type="text/javascript">
            var _paq = _paq || [];
            _paq.push(['trackPageView']);
            _paq.push(['enableLinkTracking']);
            (function() {
              var u="//analytics.code.dccouncil.us/";
              _paq.push(['setTrackerUrl', u+'piwik.php']);
              _paq.push(['setSiteId', 1]);
              var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
              g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
            })();

          window.searchHost = 'https://search.code.dccouncil.us';
          window.queryUrl = '/v1/search';
          </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <div class="container">
        <div class="right no-print search" id="search"> </div>
        <h1 id="sitename">
          <a href="/dc/council/code/">Code of the District of Columbia</a>
        </h1>
      </div>
    </header>
    <div class="main container">
      <div class="clearfix" style="width: 100%;">
        <div id="sidebar" class="col4 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li>↪ <a href="/">D.C. Law Library</a></li>
            <li>↪ <a href="/dc/council/code/">Code of the District of Columbia</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/">Title 48. Foods and Drugs.</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/chapters/9/">Chapter 9. Controlled Substances Act.</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/chapters/9/subchapters/II/">Subchapter II. Standards and Schedules.</a></li>
            <li>↪ § 48–902.14. Treatment of controlled substance analogues.</li>
          </ul>
          <h2>Previous</h2>
          <p>
            <a class="internal-link" href="/dc/council/code/sections/48-902.13.html">§ 48–902.13. Revising and republishing of schedules.</a>
          </p>
          <h2>Next</h2>
          <p>
            <a class="internal-link" href="/dc/council/code/titles/48/chapters/9/subchapters/III/">Subchapter III. Regulation of Manufacture, Distribution, and Dispensing.</a>
          </p>
          <h2>Publication Information</h2>
          <h3>Current through January 09, 2016</h3>
          <dl id="recency">
          <dt>Last codified D.C. Law:</dt>
          <dd>
            Law 21-46 effective January 09, 2016</dd>
          <dt>Last codified Emergency Law:</dt>
          <dd>
            Act 21-240 effective December 21, 2015</dd>
          <dt>Last codified Federal Law:</dt>
          <dd>
            Public Law 114-95 approved December 10, 2015</dd>
        </dl>
          <div class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/code/sections/48-902.14.html">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/code/sections/48-902.14.html">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </div>
        </div>
        <div class="col8 body">
          <h1>§ 48–902.14. Treatment of controlled substance analogues.</h1>
          <div class="toc"> </div>
          <div class="content">
            <div>
                    <div class="line-group primary-content">
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(a)</span>
                          <span>A controlled substances analogue shall, to the extent intended for human consumption, be treated for the purposes of any District of Columbia law as a controlled substance in Schedule I.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(b)</span>
                          <span>Except as provided in subsection (c) of this section, the term “controlled analogue” means:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>a substance with a chemical structure that is substantially similar to the chemical structure of a controlled substance in Schedule I or II;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>A substance that has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central system of a controlled substance in Schedule I or II; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>A substance that, with respect to a particular person, is represented to have or is intended to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to, or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of  a controlled substance in Schedule I or II.</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 1.25em">
                        <p>
                          <span class="level-num">(c)</span>
                          <span>Such term does not include:</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(1)</span>
                          <span>A controlled substance;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(2)</span>
                          <span>Any substance for which there is an approved new drug application;</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(3)</span>
                          <span>With respect to a particular person any substance, if an exemption is in effect for investigational use, for that person, under § 505 of the Federal Food, Drug, and Cosmetic Act, approved June 25, 1938 (52 Stat. 1052, 21 U.S.C. § 355) to the extent conduct with respect to such substance is pursuant to such exemption; or</span>
                        </p>
                      </div>
                      <div class="line" style="text-indent: 2.5em">
                        <p>
                          <span class="level-num">(4)</span>
                          <span>Any substance to the extent not intended for human consumption before such an exemption takes effect with respect to that substance.</span>
                        </p>
                      </div>
                    </div>
                    <div class="line-group annotations">
                      <div class="line" style="text-indent: 1.5em">
      (<a class="internal-link" href="/dc/council/laws/4-29.html">August 5, 1981, D.C. Law 4-29, § 214</a>; <a class="internal-link" href="/dc/council/laws/13-99.html">as added May 9, 2000, D.C. Law 13-99, § 2(b), 47 DCR 791</a>.)
    </div>
                    </div>
                  </div>
          </div>
        </div>
      </div>
    </div>
    <footer>
      <div class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
      </div>
    </footer>
    <script type="text/javascript" src="/js/search.js"> </script>
  </body>
</html>
